Company intelligence / Profile preview
Kibow Biotech
Newtown Square, Pennsylvania, United Stateskibowbiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Phase 2 clinical studies in CKD patients are underway to assess KT-301's safety and its ability to halt or slow progression of CKD. A Phase 2 study in end-stage renal disease (ESRD) patients undergoing dialysis is also planned.
- Therapeutic areas
- OtherCardiovascularImmunologyNephrology
- Modalities
- ProbioticsPrebioticsLive biotherapeutics
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Kibow Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kibow Biotech.